<?xml version="1.0" encoding="UTF-8"?>
<p>That previous group collaborated closely with TEVA Pharmaceutical Industries Ltd, Vifor Pharma Ltd, and SANOFI, without any active interference in the outcomes of the experts' discussion and established reference texts. The group established landmark issues in the field (
 <xref rid="B1" ref-type="bibr">1</xref>, 
 <xref rid="B2" ref-type="bibr">2</xref>), which are now under further development by similar working groups, including one within the frame of the 
 <italic>Lygature</italic> consortium in the Netherlands (
 <xref rid="B3" ref-type="bibr">3</xref>, 
 <xref rid="B4" ref-type="bibr">4</xref>).
</p>
